Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Current Leases (2020 - 2025)

Historic Current Leases for Korro Bio (KRRO) over the last 6 years, with Q3 2025 value amounting to $3.1 million.

  • Korro Bio's Current Leases changed N/A to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year change of. This contributed to the annual value of $1.3 million for FY2024, which is 3550.98% down from last year.
  • Latest data reveals that Korro Bio reported Current Leases of $3.1 million as of Q3 2025.
  • Over the past 5 years, Korro Bio's Current Leases peaked at $3.1 million during Q3 2025, and registered a low of $457000.0 during Q2 2024.
  • Over the past 5 years, Korro Bio's median Current Leases value was $1.8 million (recorded in 2022), while the average stood at $1.9 million.
  • Per our database at Business Quant, Korro Bio's Current Leases tumbled by 7887.19% in 2024 and then skyrocketed by 43063.46% in 2025.
  • Quarter analysis of 5 years shows Korro Bio's Current Leases stood at $1.7 million in 2021, then skyrocketed by 67.2% to $2.9 million in 2022, then tumbled by 31.84% to $2.0 million in 2023, then plummeted by 35.51% to $1.3 million in 2024, then surged by 144.94% to $3.1 million in 2025.
  • Its last three reported values are $3.1 million in Q3 2025, $2.4 million for Q2 2025, and $2.3 million during Q1 2025.